Head-To-Head Comparison: AmerisourceBergen Corp.

Head-To-Head Comparison: AmerisourceBergen Corp.


AmerisourceBergen Corp. and McKesson Corporation are both large-cap non-cyclical consumer goods & services companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, earnings, profitabiliy, analyst recommendations and valuation. AmerisourceBergen Corp. currently has a consensus target price of $94.46, indicating a potential upside of 2.08%.



from Biotech News